Formation and properties of lactate dehydrogenase inhibitors in NADH. 1977

C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn

We describe some characteristics of the mode of formation of inhibitors of lactate dehydrogenase from commercial NADH. Inhibitor formation is time- and concentration-dependent and also varies with the commercial source of NADH. At least two inhibitory components can form in concentrated NADH solutions. One of these can be separated from NADH by chromatography on either diethylaminoethyl-celluose or diethylaminoethyl-Sephadex; the second cannot. The NADH-associated inhibitor appeared to be present in each of the three commercial NADH preparations studied. The 260 nm/340 nm absorbance ratio was of no help in locating this inhibitor during chromatography.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry

Related Publications

C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
September 1977, Clinical chemistry,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
May 1995, Biochemistry,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
April 1978, Biochimica et biophysica acta,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
January 1977, FEBS letters,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
July 1994, Pharmaceutica acta Helvetiae,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
January 2005, Journal of applied microbiology,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
March 2014, Journal of agricultural and food chemistry,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
October 1982, Biochemical and biophysical research communications,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
January 2023, Frontiers in pharmacology,
C A Loshon, and R B McComb, and L W Bond, and G N Bowers, and W H Coleman, and R H Gwynn
October 2020, Journal of medicinal chemistry,
Copied contents to your clipboard!